Enrichment
Astrazeneca.Com
Astrazeneca.Com is a company.
FilterKey facts
- City: Cambridge
- Country: United Kingdom
- Sector: Health Care
- Foundation year: 1999
- Industry: Pharmaceuticals
- CEO: Pascal Soriot D.V.M., M.B.A.
Latest news (see all)
Bharat Biotech stresses on Covaxin's safety record after AstraZeneca admits to Covishield causing rare clotting side effects
Read: Times of India
2024-05-02
AstraZeneca admite por primera vez que su vacuna contra el Covid puede provocar trombosis
Read: Sur
2024-05-02
AstraZeneca admite que su vacuna contra la covid-19 puede provocar efectos secundarios como trombosis
Read: Sur
2024-05-02
Covid vaccine manufacturer AstraZeneca admits for the first time that its jab can provoke side effects such as thrombosis
Read: The Olive Press
2024-05-02
AstraZeneca admits its COVID vaccine can cause deadly blood clots
Read: The Washington Times
2024-04-30
Metrics
General information
Business
| assets | 105.4B $ |
| Debt | 31.4B $ |
| free cash flow | 3,757,000,000.00 |
| market cap | 184,746,000,000.00 |
| profits | 112M $ |
Visualizations
Datasets
Companies in the United Kingdom
Companies where Industry equals Pharmaceuticals
Companies where Sector equals Health Care
Stocks for Astrazeneca.Com
Source
This dashboard is based on data from: Twitter, YAHOO-FIN, YFINANCE
Updated: 1 day ago
License
This content can be used under the CC BY 4.0 license
